| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toxoplasma | 17 | 2021 | 116 | 3.310 |
Why?
|
| Toxoplasmosis | 11 | 2021 | 66 | 2.720 |
Why?
|
| Plasmodium falciparum | 12 | 2020 | 47 | 1.710 |
Why?
|
| Protozoan Vaccines | 3 | 2019 | 11 | 1.170 |
Why?
|
| Protozoan Proteins | 9 | 2018 | 73 | 1.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 600 | 1.000 |
Why?
|
| Vaccines, Subunit | 3 | 2020 | 55 | 0.850 |
Why?
|
| Antigens, Protozoan | 3 | 2020 | 21 | 0.760 |
Why?
|
| Antimalarials | 3 | 2019 | 20 | 0.740 |
Why?
|
| Epitopes | 1 | 2020 | 254 | 0.690 |
Why?
|
| Protozoan Infections | 1 | 2019 | 3 | 0.670 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2021 | 49 | 0.660 |
Why?
|
| Spermine | 1 | 2019 | 24 | 0.650 |
Why?
|
| Spermidine | 1 | 2019 | 13 | 0.640 |
Why?
|
| Polyamines | 1 | 2019 | 37 | 0.630 |
Why?
|
| Membrane Transport Proteins | 3 | 2010 | 171 | 0.600 |
Why?
|
| Purines | 3 | 2010 | 93 | 0.580 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 450 | 0.580 |
Why?
|
| Nanoparticles | 2 | 2020 | 164 | 0.570 |
Why?
|
| Centrosome | 1 | 2016 | 22 | 0.520 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 21 | 0.520 |
Why?
|
| Cell Division | 1 | 2016 | 692 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 387 | 0.440 |
Why?
|
| HLA-B7 Antigen | 3 | 2020 | 7 | 0.400 |
Why?
|
| Immunoglobulin G | 5 | 2021 | 469 | 0.390 |
Why?
|
| Antiprotozoal Agents | 3 | 2019 | 32 | 0.370 |
Why?
|
| Photosynthetic Reaction Center Complex Proteins | 2 | 2001 | 27 | 0.360 |
Why?
|
| Antibodies, Protozoan | 3 | 2021 | 42 | 0.350 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1576 | 0.350 |
Why?
|
| Cyanobacteria | 2 | 2001 | 113 | 0.340 |
Why?
|
| Point-of-Care Testing | 2 | 2021 | 24 | 0.340 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2016 | 88 | 0.330 |
Why?
|
| Malaria | 2 | 2019 | 23 | 0.330 |
Why?
|
| Morocco | 4 | 2024 | 17 | 0.310 |
Why?
|
| Biological Transport | 1 | 2008 | 401 | 0.290 |
Why?
|
| Erythrocytes | 5 | 2010 | 254 | 0.280 |
Why?
|
| Animals | 19 | 2020 | 27528 | 0.270 |
Why?
|
| Immunoglobulin M | 4 | 2021 | 164 | 0.270 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 11 | 0.240 |
Why?
|
| Mice | 8 | 2020 | 11851 | 0.230 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2015 | 20 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2006 | 677 | 0.210 |
Why?
|
| Gene Deletion | 3 | 2016 | 340 | 0.210 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 64 | 0.200 |
Why?
|
| Light | 2 | 2001 | 292 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 3252 | 0.200 |
Why?
|
| Methyltransferases | 3 | 2008 | 192 | 0.200 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2019 | 5 | 0.190 |
Why?
|
| Photosystem I Protein Complex | 1 | 2001 | 11 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 2 | 2020 | 169 | 0.190 |
Why?
|
| Host-Parasite Interactions | 2 | 2019 | 30 | 0.190 |
Why?
|
| Immunoassay | 2 | 2021 | 91 | 0.190 |
Why?
|
| Parasitemia | 2 | 2019 | 6 | 0.190 |
Why?
|
| HLA-A11 Antigen | 1 | 2020 | 2 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2014 | 449 | 0.180 |
Why?
|
| HLA-A2 Antigen | 1 | 2020 | 30 | 0.180 |
Why?
|
| Peptides | 3 | 2014 | 649 | 0.180 |
Why?
|
| Parasites | 1 | 2020 | 8 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2887 | 0.170 |
Why?
|
| Trypanosomiasis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Trypanosoma | 1 | 2019 | 3 | 0.170 |
Why?
|
| Plasmodium | 1 | 2019 | 10 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2020 | 145 | 0.160 |
Why?
|
| Parasite Load | 1 | 2019 | 2 | 0.160 |
Why?
|
| Plasmodium yoelii | 1 | 2019 | 4 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 217 | 0.160 |
Why?
|
| Colombia | 1 | 2018 | 13 | 0.160 |
Why?
|
| France | 1 | 2018 | 49 | 0.160 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2018 | 16 | 0.160 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1862 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2018 | 43 | 0.150 |
Why?
|
| Enzymes | 1 | 2018 | 47 | 0.150 |
Why?
|
| Drug Synergism | 1 | 2019 | 307 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2393 | 0.150 |
Why?
|
| Genetic Complementation Test | 2 | 2016 | 98 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 754 | 0.150 |
Why?
|
| Public Health | 1 | 2018 | 140 | 0.140 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 40 | 0.140 |
Why?
|
| Candida | 1 | 2006 | 18 | 0.140 |
Why?
|
| Cross-Priming | 1 | 2016 | 49 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1158 | 0.130 |
Why?
|
| Models, Molecular | 3 | 2018 | 1315 | 0.130 |
Why?
|
| Humans | 17 | 2024 | 89961 | 0.130 |
Why?
|
| Quinolones | 1 | 2016 | 56 | 0.130 |
Why?
|
| Amino Acids | 1 | 2006 | 246 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 2360 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2016 | 107 | 0.120 |
Why?
|
| Immunologic Memory | 1 | 2016 | 164 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.120 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 11 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 38 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 163 | 0.120 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 33 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1091 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 105 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 250 | 0.110 |
Why?
|
| Triclosan | 1 | 2013 | 10 | 0.110 |
Why?
|
| Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) | 1 | 2013 | 12 | 0.110 |
Why?
|
| United States | 4 | 2018 | 7108 | 0.110 |
Why?
|
| Spleen | 1 | 2014 | 433 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2015 | 468 | 0.100 |
Why?
|
| Morpholinos | 1 | 2012 | 13 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1452 | 0.100 |
Why?
|
| Culture Media | 2 | 2006 | 147 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 50 | 0.100 |
Why?
|
| Female | 9 | 2024 | 46587 | 0.100 |
Why?
|
| Phosphatidylcholines | 2 | 2008 | 49 | 0.100 |
Why?
|
| Benzamides | 1 | 2012 | 234 | 0.090 |
Why?
|
| Phycobilisomes | 2 | 2001 | 8 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 689 | 0.090 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2010 | 2 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 961 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2018 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 644 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 806 | 0.090 |
Why?
|
| Tubulin | 1 | 2010 | 59 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2012 | 372 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 388 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 508 | 0.080 |
Why?
|
| Xanthine | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 195 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 255 | 0.080 |
Why?
|
| Guanosine | 1 | 2008 | 30 | 0.080 |
Why?
|
| Adenine | 1 | 2008 | 88 | 0.070 |
Why?
|
| Boron Compounds | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1670 | 0.070 |
Why?
|
| Proteasome Inhibitors | 1 | 2007 | 52 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2007 | 54 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 72 | 0.070 |
Why?
|
| Guanine | 1 | 2008 | 207 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 383 | 0.070 |
Why?
|
| HIV Infections | 1 | 2016 | 846 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1866 | 0.070 |
Why?
|
| Pyrazines | 1 | 2007 | 91 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2007 | 188 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2006 | 74 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 183 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 116 | 0.060 |
Why?
|
| Prevalence | 2 | 2021 | 1250 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 885 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 247 | 0.060 |
Why?
|
| Permeability | 2 | 2015 | 138 | 0.060 |
Why?
|
| Methylation | 3 | 2010 | 269 | 0.060 |
Why?
|
| Pregnancy | 2 | 2021 | 3046 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 2064 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2016 | 232 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 54 | 0.050 |
Why?
|
| Diuron | 1 | 2001 | 4 | 0.050 |
Why?
|
| Photosystem II Protein Complex | 1 | 2001 | 21 | 0.050 |
Why?
|
| Lighting | 1 | 2001 | 33 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2026 | 0.050 |
Why?
|
| Electron Transport | 1 | 2001 | 74 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 38 | 0.050 |
Why?
|
| Adult | 4 | 2024 | 26816 | 0.050 |
Why?
|
| Laboratories | 1 | 2021 | 44 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 76 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 83 | 0.040 |
Why?
|
| Thylakoids | 1 | 2000 | 10 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 73 | 0.040 |
Why?
|
| Fluorescence | 1 | 2000 | 103 | 0.040 |
Why?
|
| Genotype | 1 | 2024 | 1852 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 19254 | 0.040 |
Why?
|
| Phenotype | 1 | 2006 | 2456 | 0.040 |
Why?
|
| Malaria, Falciparum | 2 | 2010 | 12 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 311 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2012 | 759 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 324 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 409 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 66 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 5358 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 26146 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2024 | 1380 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 146 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 491 | 0.030 |
Why?
|
| Serine | 2 | 2008 | 105 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 6409 | 0.030 |
Why?
|
| Hyphae | 1 | 2006 | 7 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 80 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 64 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 153 | 0.030 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 6 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oocysts | 1 | 2016 | 7 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1929 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 9340 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 2331 | 0.030 |
Why?
|
| Microscopy | 1 | 2006 | 87 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 305 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2415 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 69 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 149 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2010 | 440 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 895 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 16 | 0.030 |
Why?
|
| Occludin | 1 | 2015 | 66 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2006 | 207 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 81 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 333 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 282 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 283 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 123 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 466 | 0.030 |
Why?
|
| Apicomplexa | 1 | 2012 | 5 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 237 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 32 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 293 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 953 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 417 | 0.030 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2012 | 8 | 0.030 |
Why?
|
| Luciferases | 1 | 2012 | 128 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 144 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2012 | 22 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 153 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Organelles | 1 | 2012 | 56 | 0.020 |
Why?
|
| Male | 3 | 2024 | 42674 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2015 | 434 | 0.020 |
Why?
|
| Tetracyclines | 1 | 2010 | 4 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5558 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 135 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 374 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2677 | 0.020 |
Why?
|
| Floxuridine | 1 | 2010 | 10 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 29 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 163 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 423 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 389 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 27 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 323 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 2016 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 132 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 78 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 183 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2010 | 132 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 274 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3188 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 279 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 3771 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 793 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 354 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 278 | 0.020 |
Why?
|
| Ethanolamine | 1 | 2008 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 909 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 17 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2008 | 24 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 232 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2007 | 15 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 117 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 463 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 80 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 205 | 0.020 |
Why?
|
| DNA Replication | 1 | 2007 | 171 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1491 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 338 | 0.020 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2006 | 2 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 281 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 901 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 185 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 948 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3024 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1221 | 0.020 |
Why?
|
| Child | 1 | 2016 | 7240 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1227 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1664 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1983 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 2305 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3404 | 0.010 |
Why?
|